The Supreme Court rejected a bankruptcy plan for OxyContin-maker Purdue Pharma that would have allocated billions of dollars from the Sackler family to combat opioid addiction in exchange for shielding them from civil lawsuits.

The Supreme Court rejected a bankruptcy plan for OxyContin-maker Purdue Pharma that would have allocated billions of dollars from the Sackler family to combat opioid addiction in exchange for shielding them from civil lawsuits.